Support for Vaccine Challenge Trials Gains Momentum

The idea of deliberately infecting volunteers with SARS-CoV-2 has garnered significant attention as a potential avenue to speedier development, as the World Health Organization weighs in with recommendations.

| 2 min read
a gloved hand holds a vial labeled "SARS-CoV-2 vaccine, COVID-19"

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

ABOVE: © ISTOCK.COM, BILL OXFORD

In the movie Contagion, a researcher from the Centers for Disease Control and Prevention goes rogue after seeing that a vaccine candidate has worked in a monkey. She injects herself with the formula and then goes to visit her father, who is hospitalized with the fictional virus MEV-1, to expose herself to the pathogen. She doesn’t fall ill, and the success of her risky act accelerates the rollout of a vaccine against the virus.

Contagion fans have noted a number of parallels between the movie’s fictional disease and COVID-19, and deliberate exposure to test a vaccine’s efficacy may be the next one. Some researchers are advocating for a more systematic version of the film’s approach, and the idea is gaining traction. The World Health Organization released guidelines last week on how such “challenge trials” might be conducted, and the US National Institutes of Health (NIH) ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Shawna Williams

    Shawna was an editor at The Scientist from 2017 through 2022. She holds a bachelor's degree in biochemistry from Colorado College and a graduate certificate and science communication from the University of California, Santa Cruz.
Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo